S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
OTCMKTS:IMLFF

InMed Pharmaceuticals (IMLFF) Stock Forecast, Price & News

$1.28
-0.04 (-3.03%)
(As of 06/2/2023 ET)
Compare
Today's Range
$1.22
▼
$1.35
50-Day Range
$1.08
▼
$1.40
52-Week Range
$3.04
▼
$10.63
Volume
69,351 shs
Average Volume
11,369 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlinesShort Interest

IMLFF stock logo

About InMed Pharmaceuticals (OTCMKTS:IMLFF) Stock

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, it works on IND-enabling pharmacology and preclinical toxicology studies. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.

Receive IMLFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

IMLFF Stock News Headlines

May 31, 2023 | americanbankingnews.com
InMed Pharmaceuticals (OTCMKTS:IMLFF) Stock Price Down 0.8%
May 16, 2023 | marketwatch.com
CannabisNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update
June 3, 2023 | Legacy Research (Affiliate) (Ad)
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
May 16, 2023 | msn.com
InMed Pharmaceuticals Stock Trading Higher On Q3 Sales Growth Of 234%, Here Is What You Need To Know
March 29, 2023 | americanbankingnews.com
InMed Pharmaceuticals (OTCMKTS:IMLFF) Shares Down 3.1%
March 21, 2023 | benzinga.com
InMed Pharmaceuticals Stock (NASDAQ:INM), Short Interest Report
January 21, 2023 | seekingalpha.com
INM InMed Pharmaceuticals Inc.
January 10, 2023 | technews.tmcnet.com
InMed Provides Business Update and Milestones for 2023
June 3, 2023 | Legacy Research (Affiliate) (Ad)
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
November 22, 2022 | msn.com
InMed Pharmaceuticals Secures $6M Via Private Placement
September 23, 2022 | benzinga.com
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
September 13, 2022 | yahoo.com
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
September 9, 2022 | finance.yahoo.com
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
August 24, 2022 | finanznachrichten.de
InMed Pharmaceuticals Inc.: InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria
August 23, 2022 | finance.yahoo.com
InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria
June 15, 2022 | apnews.com
InMed Pharmaceuticals Closes $5M Direct, Private Placement Offerings
June 6, 2022 | finance.yahoo.com
InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
June 1, 2022 | apnews.com
InMed Pharmaceuticals (INM): Health and Wellness Product Launches
November 10, 2021 | nasdaq.com
InMed Pharmaceuticals Inc. (INM) Reports Q1 Loss, Lags Revenue Estimates
October 27, 2021 | benzinga.com
DeFi Will End Poorly Without Investor Protections, Gary Gensler Says
September 13, 2021 | benzinga.com
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids
September 13, 2021 | benzinga.com
InMed Pharmaceuticals Inc. Enters Agreement For 'Transformative' Acquisition Of Leading Manufacturer Of Rare Cannabinoids
September 7, 2021 | benzinga.com
Where Do Blunts Come From? Who Was The First To Smoke One? Snoop Dogg Weighs In
September 6, 2021 | benzinga.com
What You Need To Know About CBD Hash
September 4, 2021 | benzinga.com
LEGAL: New, Stunning Web Series Looks Into The First Country To Legalize Cannabis And The People Thriving Thanks To It
September 2, 2021 | benzinga.com
Terpene Producer Eybna Teams Up With Cannabis Brands Spherex And Orchid Essentials
August 26, 2021 | benzinga.com
Can Ketamine Be Used To Treat Gambling Addiction? Awakn Life Sciences Wants To Find Out
See More Headlines

IMLFF Price History

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IMLFF
CUSIP
N/A
CIK
N/A
Web
www.inmedpharma.com
Phone
(604) 669-7207
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Eric A. Adams (Age 56)
    Pres, CEO & Director
  • Mr. Bruce S. Colwill C.A. (Age 55)
    CPA, CA, CFO & Corp. Sec.
  • Ms. Alexandra D. J. Mancini (Age 67)
    Sr. VP of Clinical & Regulatory Affairs
  • Dr. Eric Chih-Hsien Hsu (Age 50)
    Sr. VP of Preclinical R&D
  • Mr. Michael Woudenberg P.Eng. (Age 53)
    VP of Chemistry, Manufacturing & Controls
  • Dr. Sazzad Hossain
    Co-Founder
  • Mr. Brendan Payne
    Director of Investor Relations
  • Mr. Richard Hoy
    VP of Sales & Marketing
  • Dr. Ado Muhammad
    Sr. Consultant of Medical Affairs

Key Competitors

View All Competitors













IMLFF Stock - Frequently Asked Questions

How have IMLFF shares performed in 2023?

InMed Pharmaceuticals' stock was trading at $4.88 at the start of the year. Since then, IMLFF shares have decreased by 73.8% and is now trading at $1.28.
View the best growth stocks for 2023 here.

What is InMed Pharmaceuticals' stock symbol?

InMed Pharmaceuticals trades on the OTCMKTS under the ticker symbol "IMLFF."

How do I buy shares of InMed Pharmaceuticals?

Shares of IMLFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InMed Pharmaceuticals' stock price today?

One share of IMLFF stock can currently be purchased for approximately $1.28.

How can I contact InMed Pharmaceuticals?

The official website for the company is www.inmedpharma.com. The company can be reached via phone at (604) 669-7207.

This page (OTCMKTS:IMLFF) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -